Brainstem metastases treated with Gamma Knife stereotactic radiosurgery: the Indiana University Health experience
Brainstem metastases offer a unique challenge in cancer treatment, yet stereotactic radiosurgery (SRS) has proven to be an effective modality in treating these tumors. This report discusses the clinical outcomes of patients with brainstem metastases treated at Indiana University with Gamma Knife (GK...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2018-01-01
|
| Series: | CNS Oncology |
| Subjects: | |
| Online Access: | https://www.futuremedicine.com/doi/10.2217/cns-2017-0029 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850152288090324992 |
|---|---|
| author | Ajay Patel Homan Mohammadi Tuo Dong Kevin Ren-Yeh Shiue Douglas Frye Yi Le Shaheryar Ansari Gordon A Watson James C Miller Tim Lautenschlaeger |
| author_facet | Ajay Patel Homan Mohammadi Tuo Dong Kevin Ren-Yeh Shiue Douglas Frye Yi Le Shaheryar Ansari Gordon A Watson James C Miller Tim Lautenschlaeger |
| author_sort | Ajay Patel |
| collection | DOAJ |
| description | Brainstem metastases offer a unique challenge in cancer treatment, yet stereotactic radiosurgery (SRS) has proven to be an effective modality in treating these tumors. This report discusses the clinical outcomes of patients with brainstem metastases treated at Indiana University with Gamma Knife (GK) radiosurgery from 2008 to 2016. 19 brainstem metastases from 14 patients who had follow-up brain imaging were identified. Median tumor volume was 0.04 cc (range: 0.01–2.0 cc). Median prescribed dose was 17.5 Gy to the 50% isodose line (range: 14–22 Gy). Median survival after GK SRS treatment to brainstem lesion was 17.2 months (range: 2.8–45.6 months). The experience at Indiana University confirms the safety and efficacy of range of GK SRS prescription doses (14–22 Gy) to brainstem metastases. |
| format | Article |
| id | doaj-art-1b6eab55b47e4d83adf30644541f9fcf |
| institution | OA Journals |
| issn | 2045-0907 2045-0915 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | CNS Oncology |
| spelling | doaj-art-1b6eab55b47e4d83adf30644541f9fcf2025-08-20T02:26:02ZengTaylor & Francis GroupCNS Oncology2045-09072045-09152018-01-0171152310.2217/cns-2017-0029Brainstem metastases treated with Gamma Knife stereotactic radiosurgery: the Indiana University Health experienceAjay Patel0Homan Mohammadi1Tuo Dong2Kevin Ren-Yeh Shiue3Douglas Frye4Yi Le5Shaheryar Ansari6Gordon A Watson7James C Miller8Tim Lautenschlaeger91Indiana University School of Medicine, Indianapolis, IN 46202, USA1Indiana University School of Medicine, Indianapolis, IN 46202, USA1Indiana University School of Medicine, Indianapolis, IN 46202, USA1Indiana University School of Medicine, Indianapolis, IN 46202, USA2Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN 46202, USA2Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN 46202, USA1Indiana University School of Medicine, Indianapolis, IN 46202, USA2Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN 46202, USA3Goodman Campbell Brain & Spine & Department of Neurological Surgery, Indiana University, Indianapolis, IN 46202, USA2Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN 46202, USABrainstem metastases offer a unique challenge in cancer treatment, yet stereotactic radiosurgery (SRS) has proven to be an effective modality in treating these tumors. This report discusses the clinical outcomes of patients with brainstem metastases treated at Indiana University with Gamma Knife (GK) radiosurgery from 2008 to 2016. 19 brainstem metastases from 14 patients who had follow-up brain imaging were identified. Median tumor volume was 0.04 cc (range: 0.01–2.0 cc). Median prescribed dose was 17.5 Gy to the 50% isodose line (range: 14–22 Gy). Median survival after GK SRS treatment to brainstem lesion was 17.2 months (range: 2.8–45.6 months). The experience at Indiana University confirms the safety and efficacy of range of GK SRS prescription doses (14–22 Gy) to brainstem metastases.https://www.futuremedicine.com/doi/10.2217/cns-2017-0029brainstemGamma Knifemetastasisradiosurgery |
| spellingShingle | Ajay Patel Homan Mohammadi Tuo Dong Kevin Ren-Yeh Shiue Douglas Frye Yi Le Shaheryar Ansari Gordon A Watson James C Miller Tim Lautenschlaeger Brainstem metastases treated with Gamma Knife stereotactic radiosurgery: the Indiana University Health experience CNS Oncology brainstem Gamma Knife metastasis radiosurgery |
| title | Brainstem metastases treated with Gamma Knife stereotactic radiosurgery: the Indiana University Health experience |
| title_full | Brainstem metastases treated with Gamma Knife stereotactic radiosurgery: the Indiana University Health experience |
| title_fullStr | Brainstem metastases treated with Gamma Knife stereotactic radiosurgery: the Indiana University Health experience |
| title_full_unstemmed | Brainstem metastases treated with Gamma Knife stereotactic radiosurgery: the Indiana University Health experience |
| title_short | Brainstem metastases treated with Gamma Knife stereotactic radiosurgery: the Indiana University Health experience |
| title_sort | brainstem metastases treated with gamma knife stereotactic radiosurgery the indiana university health experience |
| topic | brainstem Gamma Knife metastasis radiosurgery |
| url | https://www.futuremedicine.com/doi/10.2217/cns-2017-0029 |
| work_keys_str_mv | AT ajaypatel brainstemmetastasestreatedwithgammaknifestereotacticradiosurgerytheindianauniversityhealthexperience AT homanmohammadi brainstemmetastasestreatedwithgammaknifestereotacticradiosurgerytheindianauniversityhealthexperience AT tuodong brainstemmetastasestreatedwithgammaknifestereotacticradiosurgerytheindianauniversityhealthexperience AT kevinrenyehshiue brainstemmetastasestreatedwithgammaknifestereotacticradiosurgerytheindianauniversityhealthexperience AT douglasfrye brainstemmetastasestreatedwithgammaknifestereotacticradiosurgerytheindianauniversityhealthexperience AT yile brainstemmetastasestreatedwithgammaknifestereotacticradiosurgerytheindianauniversityhealthexperience AT shaheryaransari brainstemmetastasestreatedwithgammaknifestereotacticradiosurgerytheindianauniversityhealthexperience AT gordonawatson brainstemmetastasestreatedwithgammaknifestereotacticradiosurgerytheindianauniversityhealthexperience AT jamescmiller brainstemmetastasestreatedwithgammaknifestereotacticradiosurgerytheindianauniversityhealthexperience AT timlautenschlaeger brainstemmetastasestreatedwithgammaknifestereotacticradiosurgerytheindianauniversityhealthexperience |